Optometry News

NASHVILLE, Tenn. — Alcon’s U.S. pharmaceutical division shared its focus on glaucoma and dry eye with attendees at Optometry’s Meeting.

The Council for Medical Specialty Societies, or CMSS, announced the launch of a new initiative that aims to reduce clinicians’ reliance on race in clinical decision-making and patient harms.

Believe it or not, it’s only been 15 years since the use of electronic health records became common in the U.S.

NASHVILLE, Tenn. — Successful multifocal contact lens fitting starts with a good refraction, an industry executive said here at Optometry’s Meeting.

NASHVILLE, Tenn. — BioTissue’s CAM360 AmnioGraft is showing early success in treating mild to moderate dry eye, according to a company executive here at Optometry’s Meeting.

NASHVILLE, Tenn. — The use of AI in optometry is poised to create new opportunities for eye care providers, according to keynote speaker and leading AI transformation advisor Tom Lawry at Optometry’s Meeting.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Patricio Schlottmann, MD, discusses dual inhibition of the Ang-2 and VEGF pathways.

NASHVILLE, Tenn. — Short-term noninvasive tear breakup time increased with use of Lumify eye drops in cohort of patients with and without dry eye disease, according to a poster presented at Optometry’s Meeting.

The FDA granted priority review of the biologics license application for NT-501 as a treatment for macular telangiectasia type 2, according to a press release from Neurotech Pharmaceuticals.

NASHVILLE, Tenn. — A preservative-free brimonidine tartrate ophthalmic solution was statistically noninferior to Bausch + Lomb’s Lumify, offering an alternative option for ocular redness relief, according to a poster at Optometry’s Meeting.